The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2019 | Classifying MPNs with molecular genetic markers
Here, Torsten Haferlach, MD, from the Munich Leukemia Laboratory, Munich, Germany, discusses how discrimination between types of myeloproliferative neoplasms (MPNs) can be achieved with genomic analysis using techniques such as next-generation sequencing (NGS), rather than relying solely on histological analysis. Prof. Haferlach was speaking at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
